Pfizer (PFE)
42.91
-0.20 (0.46%)
Upcoming Events
Latest Headlines
U.S. CDC advisers approve adding COVID shots to vaccine schedules
October 20, 2022 3:32 PM - StreetInsider
CDC panel votes to add COVID shots to kids' vaccine schedule - DJ
October 20, 2022 1:30 PM - StreetInsider
Erasca, Inc (ERAS) Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
October 20, 2022 8:00 AM - StreetInsider
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
October 20, 2022 8:00 AM - Globe NewsWire
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
October 20, 2022 8:00 AM - StreetInsider
Pfizer (PFE) and BioNTech (BNTX) Receive Positive CHMP Opinion for COMIRNATY in Children 6 Months to less than 5 Years in the European Union
October 19, 2022 11:46 AM - StreetInsider
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union
October 19, 2022 11:45 AM - StreetInsider
EMA Recommends MRNA Covid Vaccines From 4 Months Of Age - Bloomberg
October 19, 2022 11:21 AM - StreetInsider
Form 4 PFIZER INC For: Oct 14 Filed by: JOHNSON RADY A
October 18, 2022 7:12 PM - SEC Filing
Form 4 PFIZER INC For: Oct 14 Filed by: BOURLA ALBERT
October 18, 2022 7:12 PM - SEC Filing
Form 4 PFIZER INC For: Oct 14 Filed by: DAMICO JENNIFER B.
October 18, 2022 7:12 PM - SEC Filing
Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022
October 18, 2022 12:00 PM - BizWire
Form 4 PFIZER INC For: Oct 12 Filed by: DAMICO JENNIFER B.
October 13, 2022 6:15 PM - SEC Filing
Form 4 PFIZER INC For: Oct 12 Filed by: JOHNSON RADY A
October 13, 2022 6:15 PM - SEC Filing
Form 4 PFIZER INC For: Oct 12 Filed by: BOURLA ALBERT
October 13, 2022 6:15 PM - SEC Filing
GSK: Trials for Respiratory Virus Vaccine "Positive"
October 13, 2022 7:27 AM - StreetInsider
BioNTech SE (BNTX) and Pfizer (PFE) Report Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster
October 13, 2022 6:47 AM - StreetInsider
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
October 13, 2022 6:45 AM - BizWire
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
October 13, 2022 6:45 AM - StreetInsider
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
October 12, 2022 10:30 AM - StreetInsider
Pfizer (PFE), BioNTech (BNTX) Confirm U.S. FDA EUA for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
October 12, 2022 10:16 AM - StreetInsider
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
October 12, 2022 10:16 AM - BizWire
U.S. authorizes updated COVID booster shots for children as young as 5
October 12, 2022 9:58 AM - StreetInsider
FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (MRNA) (PFE) (BNTX)
October 12, 2022 9:48 AM - StreetInsider
Pfizer (PFE) PT Raised to $50 at Morgan Stanley
October 12, 2022 6:03 AM - StreetInsider
Pfizer (PFE) PT Lowered to $44 at Barclays
October 12, 2022 5:50 AM - StreetInsider
Pfizer (PFE) PT Lowered to $50 at JPMorgan
October 11, 2022 9:11 AM - StreetInsider
Pfizer (PFE) PT Lowered to $48 at SVB Leerink on Likely Q3 'Miss'
October 11, 2022 7:39 AM - StreetInsider
Pfizer (PFE) and BioNTech's (BNTX) Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster Receives Health Canada Authorization for Individuals 12 Years of Age and Older
October 7, 2022 11:04 AM - StreetInsider
COVID rebound after Pfizer treatment likely due to robust immune response, study finds
October 6, 2022 4:45 PM - StreetInsider
Pfizer (PFE) Completes Acquisition of Global Blood Therapeutics (GBT)
October 5, 2022 9:03 AM - StreetInsider
Pfizer Completes Acquisition of Global Blood Therapeutics
October 5, 2022 9:02 AM - BizWire
Pfizer COVID vaccine clears Japan panel for use with young children
October 5, 2022 6:26 AM - StreetInsider
Voyager Therapeutics (VYGR) Announces Pfizer License of Next-Generation AAV Capsid for Rare Neurologic Disease Target
October 4, 2022 7:02 AM - StreetInsider
Pfizer (PFE) Reports Positive Topline Results from Phase 3 TALAPRO-2 Trial
October 4, 2022 6:45 AM - StreetInsider
Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
October 4, 2022 6:45 AM - BizWire
Form 4 PFIZER INC For: Sep 30 Filed by: SMITH JAMES C
October 3, 2022 7:09 PM - SEC Filing
Form 4 PFIZER INC For: Sep 30 Filed by: Quincey James
October 3, 2022 7:09 PM - SEC Filing
Form 4 PFIZER INC For: Sep 30 Filed by: NARAYEN SHANTANU
October 3, 2022 7:09 PM - SEC Filing
Form 4 PFIZER INC For: Sep 30 Filed by: Echevarria Joseph
October 3, 2022 7:08 PM - SEC Filing
Form 4 PFIZER INC For: Sep 30 Filed by: JOHNSON RADY A
October 3, 2022 4:54 PM - SEC Filing
Form 4 PFIZER INC For: Sep 30 Filed by: DAMICO JENNIFER B.
October 3, 2022 4:54 PM - SEC Filing
Form 4 PFIZER INC For: Sep 30 Filed by: BOURLA ALBERT
October 3, 2022 4:53 PM - SEC Filing
Pfizer (PFE) Completes Acquisition of Biohaven Pharmaceuticals
October 3, 2022 1:01 PM - StreetInsider
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
October 3, 2022 1:01 PM - BizWire
Biohaven Pharma (BHVN) says closing of acquisition by Pfizer (PFE) is expected to be on October 3
September 27, 2022 5:32 PM - StreetInsider
Fitch Revises Pfizer's Outlook to Positive; Affirms IDR at 'A'
September 26, 2022 2:29 PM - StreetInsider
Pfizer/BioNTech seek FDA nod for new COVID boosters for children
September 26, 2022 7:20 AM - StreetInsider
BioNTech SE (BNTX) and Pfizer (PFE) Submit FDA Application for EMA of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children Aged 5-11
September 26, 2022 6:45 AM - StreetInsider
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
September 26, 2022 6:45 AM - BizWire
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
September 26, 2022 6:45 AM - StreetInsider
U.S. rollout of new COVID boosters off to slow start
September 23, 2022 8:47 AM - StreetInsider
Pfizer (PFE) Declares $0.40 Quarterly Dividend; 3.6% Yield
September 22, 2022 8:03 AM - StreetInsider
Pfizer Declares Fourth-Quarter 2022 Dividend
September 22, 2022 8:00 AM - BizWire
BMO Capital Reiterates Outperform Rating on Pfizer (PFE) as Early-Stage Oral GLP-1s Show Promise in T2D & Obesity
September 22, 2022 7:35 AM - StreetInsider
Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
September 22, 2022 6:45 AM - BizWire
Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts
September 20, 2022 10:00 AM - BizWire
Pfizer (PFE) Reports Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in EU
September 19, 2022 6:45 AM - StreetInsider
Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
September 19, 2022 6:45 AM - BizWire
Form 4 PFIZER INC For: Sep 15 Filed by: JOHNSON RADY A
September 16, 2022 4:03 PM - SEC Filing
Form 4 PFIZER INC For: Sep 15 Filed by: BOURLA ALBERT
September 16, 2022 4:03 PM - SEC Filing
Form 4 PFIZER INC For: Sep 15 Filed by: DAMICO JENNIFER B.
September 16, 2022 4:03 PM - SEC Filing
Pfizer (PFE), BioNTech (BNTX) Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
September 16, 2022 8:00 AM - StreetInsider
Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
September 16, 2022 8:00 AM - StreetInsider
Pfizer (PFE): Meningococcal Ph3 Vax Data an 'Incremental Positive' - Morgan Stanley
September 16, 2022 5:40 AM - StreetInsider
Pfizer (PFE) Reports Positive Top-Line Results from Phase 3 Trial of MenABCWY
September 15, 2022 6:45 AM - StreetInsider
Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
September 15, 2022 6:45 AM - BizWire
Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022
September 14, 2022 10:00 AM - BizWire
Pfizer (PFE) Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022 6:45 AM - StreetInsider
Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022 6:45 AM - BizWire
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer
September 13, 2022 8:45 AM - PR NewsWire
Pfizer (PFE), BioNTech (BNTX) Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 12, 2022 11:20 AM - StreetInsider
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 12, 2022 11:20 AM - BizWire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 12, 2022 11:20 AM - StreetInsider
Health Canada authorizes Pfizer (PFE) -BioNTech (BNTX) COVID-19 vaccine for children six months to four years of age
September 9, 2022 11:05 AM - StreetInsider
Pfizer (PFE) Announces FDA and EMA Acceptance of Ritlecitinib for Alopecia Areata
September 9, 2022 6:47 AM - StreetInsider
FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
September 9, 2022 6:45 AM - BizWire
Pfizer (PFE) Group B Streptococcus Vaccine Candidate Granted FDA Breakthrough Therapy Designation
September 7, 2022 6:51 AM - StreetInsider
FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women
September 7, 2022 6:45 AM - BizWire
ICON Releases its 2021 ESG Report
September 6, 2022 4:15 PM - BizWire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 6, 2022 11:00 AM - BizWire
Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action
September 6, 2022 10:00 AM - BizWire
Pfizer (PFE) Wins CDC Panel Vote On Ba.4/5 Variant Booster - Bloomberg
September 1, 2022 5:47 PM - StreetInsider
Form 4 PFIZER INC For: Aug 31 Filed by: JOHNSON RADY A
September 1, 2022 4:03 PM - SEC Filing
Form 4 PFIZER INC For: Aug 31 Filed by: DAMICO JENNIFER B.
September 1, 2022 4:02 PM - SEC Filing
Form 4 PFIZER INC For: Aug 31 Filed by: BOURLA ALBERT
September 1, 2022 4:02 PM - SEC Filing
Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
September 1, 2022 10:00 AM - BizWire
BioNTech SE (BNTX) and Pfizer (PFE) Receive Positive CHMP Opinion for COVID-19 Vaccine Booster in EU
September 1, 2022 9:46 AM - StreetInsider
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 1, 2022 9:45 AM - BizWire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 1, 2022 9:45 AM - StreetInsider
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
August 31, 2022 10:18 AM - BizWire
Pfizer (PFE), BioNTech SE (BNTX) Confirm FDA EUA for Omicron Booster
August 31, 2022 10:15 AM - StreetInsider
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
August 31, 2022 10:13 AM - StreetInsider
FDA okays Moderna (MRNA), Pfizer (PFE) Omicron boosters
August 31, 2022 9:55 AM - StreetInsider
Moderna (MRNA) Sues Pfizer (PFE) and BioNTech (BNTX) Over Covid Vaccine Technology
August 26, 2022 12:45 PM - StreetInsider
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
August 26, 2022 9:52 AM - BizWire
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
August 26, 2022 9:45 AM - StreetInsider
Moderna (MRNA) Sues Pfizer (PFE) and BioNTech (BNTX) for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform
August 26, 2022 8:02 AM - StreetInsider
Pfizer (PFE) Reports Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
August 25, 2022 6:45 AM - StreetInsider
Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
August 25, 2022 6:45 AM - BizWire
Pfizer (PFE) and BioNTech (BNTX) Report Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years Old
August 23, 2022 6:45 AM - StreetInsider
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
August 23, 2022 6:45 AM - BizWire
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
August 23, 2022 6:45 AM - StreetInsider
BioNTech SE (BNTX) and Pfizer (PFE) Submit FDA Application for EMA of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
August 22, 2022 10:31 AM - StreetInsider
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
August 22, 2022 10:30 AM - BizWire
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
August 22, 2022 10:30 AM - StreetInsider
Pfizer (PFE) Ordered by FDA to Test Impact of Repeat Course of Paxlovid - BBG
August 19, 2022 3:48 PM - StreetInsider
Pfizer (PFE) To Study Repeat Paxlovid Regimen At Us FDA Order - Bloomberg
August 19, 2022 2:56 PM - StreetInsider
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
August 19, 2022 10:00 AM - BizWire
Moderna (MRNA), Pfizer (PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments
August 18, 2022 12:03 PM - StreetInsider
US Plans For End Of Covid-19 Shot, Treatment Coverage - WSJ
August 18, 2022 12:01 PM - StreetInsider
Form 4 PFIZER INC For: Aug 15 Filed by: JOHNSON RADY A
August 16, 2022 3:44 PM - SEC Filing
Form 4 PFIZER INC For: Aug 15 Filed by: DAMICO JENNIFER B.
August 16, 2022 3:44 PM - SEC Filing
Form 4 PFIZER INC For: Aug 15 Filed by: BOURLA ALBERT
August 16, 2022 3:44 PM - SEC Filing
ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
August 15, 2022 5:00 PM - StreetInsider
Pfizer (PFE) Reports Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants
August 12, 2022 6:46 AM - StreetInsider
Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants
August 12, 2022 6:45 AM - BizWire
Pfizer (PFE) option IV near low end of range
August 12, 2022 4:26 AM - StreetInsider
Stocks expected to have increasing option volume: PBR ILMN HLN GSK SNY PFE
August 12, 2022 3:53 AM - StreetInsider
NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team
August 11, 2022 2:30 PM - BizWire
Form 10-Q PFIZER INC For: Jul 03
August 10, 2022 4:28 PM - SEC Filing
GLOBAL BLOOD THERAPEUTICS, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of GBT and Encourages Investors to Contact the Firm
August 9, 2022 4:49 PM - StreetInsider
Pfizer (PFE) and Valneva (VALN) Initiate Phase 3 Study of VLA15
August 8, 2022 4:47 PM - StreetInsider
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
August 8, 2022 4:45 PM - BizWire
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
August 8, 2022 4:45 PM - StreetInsider
Global Blood Therapeutics (GBT) Shares Tick Higher After Pfizer Buy Agreed
August 8, 2022 11:33 AM - StreetInsider
Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion deal
August 8, 2022 6:48 AM - StreetInsider
Pfizer (PFE) to Acquire Global Blood Therapeutics (GBT) for $5.4 Billion, $68.50 Per Share
August 8, 2022 6:46 AM - StreetInsider
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
August 8, 2022 6:45 AM - BizWire
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
August 8, 2022 6:45 AM - Globe NewsWire
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
August 5, 2022 8:50 PM - Globe NewsWire
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
August 5, 2022 8:50 PM - StreetInsider
Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
August 5, 2022 11:54 AM - StreetInsider
UPDATE: Pfizer (PFE) is in advanced talks to buy Global Blood Therapeutics (GBT) - WSJ
August 5, 2022 11:35 AM - StreetInsider
Form 4 PFIZER INC For: Jul 29 Filed by: JOHNSON RADY A
August 1, 2022 3:42 PM - SEC Filing
Form 4 PFIZER INC For: Jul 29 Filed by: DAMICO JENNIFER B.
August 1, 2022 3:42 PM - SEC Filing
Form 4 PFIZER INC For: Jul 29 Filed by: BOURLA ALBERT
August 1, 2022 3:42 PM - SEC Filing
Pfizer (PFE) PT Raised to $64 at Truist Securities
August 1, 2022 7:11 AM - StreetInsider
Pfizer (PFE) PT Raised to $64 at Truist Securities; 'Incrementally more positive' following results
July 29, 2022 12:11 PM - StreetInsider
ViiV Healthcare presents positive five-year data at AIDS 2022, demonstrating the durability of fostemsavir in people living with HIV who are heavily treatment-experienced
July 29, 2022 8:04 AM - BizWire
Pfizer (PFE) PT Lowered to $50 at Barclays
July 29, 2022 4:36 AM - StreetInsider
Popular stocks increasing volume: PFE TWTR AMC SNAP SHOP INTC
July 28, 2022 4:13 PM - StreetInsider
Pfizer (PFE) Earnings Growth 'Underappreciated' - Cantor Fitzgerald
July 28, 2022 1:32 PM - StreetInsider
ViiV Healthcare Announces New Data at AIDS 2022 From Unblinded Phase of HPTN 084 Study in Women in Sub-Saharan Africa Showing Continued Superior Efficacy of Injectable Cabotegravir Long-Acting for PrE
July 28, 2022 10:05 AM - BizWire
ViiV Healthcare and the Medicines Patent Pool Sign New Voluntary Licensing Agreement to Expand Access to Innovative Long-Acting HIV Prevention Medicine
July 28, 2022 10:04 AM - BizWire
Form 8-K PFIZER INC For: Jul 28
July 28, 2022 8:09 AM - SEC Filing
Pfizer leaves COVID product forecast unchanged, shares fall
July 28, 2022 6:50 AM - StreetInsider
Pfizer (PFE) Tops Q2 EPS by 33c, Reaffirms FY22 Comirnaty and Paxlovid Sales Guidance
July 28, 2022 6:46 AM - StreetInsider
PFIZER REPORTS SECOND-QUARTER 2022 RESULTS
July 28, 2022 6:45 AM - BizWire
Pfizer (PFE) calls more active than put into quarter results and outlook
July 27, 2022 10:46 AM - StreetInsider
BioNTech SE (BNTX) and Pfizer (PFE) Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
July 27, 2022 6:47 AM - StreetInsider
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
July 27, 2022 6:45 AM - StreetInsider
Pfizer (PFE) July weekly 52 straddle priced for a move of 4% into quarter results
July 27, 2022 5:16 AM - StreetInsider
BioNTech, Pfizer sue CureVac in U.S. over COVID-19 vaccine patent claims
July 26, 2022 11:59 AM - StreetInsider
Pfizer loses U.S. appeal over co-pays for heart failure patients
July 25, 2022 11:33 AM - StreetInsider
Full Article List